Cedra Clinical Research, a US contract research organisation, will begin conducting Phase I trials electronically with LabPas CT in August 2007
"We are extremely pleased with LabPas CT," said Sherilyn Adcock, vice president and chief science officer at Cedra.
"The software and the implementation have exceeded our expectations in terms of functionality.
"The LabPas team has been great to work with and adaptable to our needs.
"We look forward to the enhanced quality and efficiency that will result from conducting our Phase I trials electronically".
John Rosenblum, president and CEO of Green Mountain Logic, developer of LabPas CT, noted, "Cedra's unsurpassed commitment to quality and sophisticated approach to clinical trials have been an inspiration.
"As it goes live with LabPas CT it will set a new standard for Phase I research data capture and reporting".
Cedra is one of seven highly-regarded clinical research organisations to have selected LabPas CT in the past year.
Cedra has enrolled more than 14,000 volunteers in Phase I clinical trials and has conducted more than 600 Phase I-IV research studies.
The Cedra Clinical Research San Antonio facility includes 200+ Phase I beds and a state-of-the-art clinical reference laboratory.
There are 100+ Phase I beds in the Cedra Clinical Research Austin facility.
Both facilities have planned expansions in space and services in 2007 as well as expansion of Cedra's bioanalytical services.
LabPas CT software for Phase I clinical trials improves margins, decreases liability and increases clinical capabilities, says Green Mountain Logic.
It comprehensively manages Phase I clinical trials, from recruiting through export to EDC.
LabPas CT is xaid to be unique in its intuitive approach and adaptability to individual study protocols.
